Reports
Sale
Global Venous Stents Market Size, Share, Report: By Technology: Iliac Vein Stent Technology, Wall Stent Technology; By Material: Nitinol, Elgiloy; By Indication: Chronic Deep Vein Thrombosis, Post-Thrombotic Syndrome (PTS), May-Thurner’s Syndrome, Others; By Application; By End User Regional Analysis; Supplier Landscape; 2024-2032
Global Venous Stents Market Outlook
The global venous stents market size was valued at USD 1.03 billion in 2023, driven by the prevalence of venous diseases globally. The market is expected to grow at a CAGR of 8.4% during the forecast period of 2024-2032, with the values likely to rise from USD 1.12 billion in 2024 to USD 2.14 billion by 2032.
Venous Stents: Introduction
A venous stent is a small mesh like tube, put inside a blocked or narrowed vein wall to free the passage. It is available in different sizes and materials to provide desired mechanical properties. Self-expanding and balloon expandable stents are two major categories, each one of these categories has a specific clinical performance and deployment procedure.
Venous stents can help people with compressed or narrowed veins. They are mostly used in people suffering from deep vein thrombosis, May-Thurner syndrome, Nutcracker syndrome, or post-thrombotic syndrome.
Global Venous Stents Market Analysis
Deep vein thrombosis is a blood clot (thrombus) formed in a deep vein, mostly in legs. This condition demands immediate attention because the blood clot can travel through the bloodstream to the lungs and block blood flow (pulmonary embolism). Venous stent implantation is a common treatment for DVT and PE. Approximately 60,000-100,000 Americans die of DVT/PE (also called venous thromboembolism, or VTE) every year. To prevent the morbidities associated with the condition, surgical procedures have grown common, as a result, venous stent market value has increased over the years.
With the rising number of patients with respiratory and cardiovascular vascular diseases, stents are extensively used to reshape veins and arteries to restore their function. The existing models of stents are suitable for all groups. However, with patients’ individual medical case and other reasons, there is an increased need for custom medical stents as well.
In the coming years, we can observe 3D printing technology that allows high customization, improving stent implantation, and reducing expenditure as well as time. This indicates that venous stent market growth can be awaited in the future years.
The market size for venous stents is also expected to increase with the major merger acquisitions led by healthcare industry pioneers. For instance, Olympus corporation has agreed to acquire Taewoong Medical Co., Ltd, a Korea based medical device company manufacturing gastrointestinal stents (GI). Similarly, Philips has already acquired Vesper Medical in the past. Hence, competition among the leaders is set to open a new realm of innovation and lead the market growth in the future.
Global Venous Stents Market Segmentations
Market Breakup by Technology
- Iliac Vein Stent Technology
- Wall stent Technology
Market Breakup by Material
- Nitinol
- Elgiloy
Market Breakup by Indication
- Chronic Deep Vein Thrombosis
- Post-Thrombotic Syndrome (PTS)
- May-Thurner’s Syndrome
- Pelvic Congestion Syndrome (PCS)
- Others
Market Breakup by Application
- Leg
- Chest
- Abdomen
- Others
Market Breakup by End User
- Hospitals
- Ambulatory Surgery Centers
- Specialty Clinics
- Cardiac Catheterization Labs
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Venous Stents Market Overview
The United States was leading the global market for venous stents during the historical period. This can be attributed to the high demand of devices due to prevalence of diseases like chronic deep vein thrombosis and pulmonary embolism, among others. It is also imperative to mention that the region also has a profound infrastructure and healthcare faculty to carry out surgical procedures on a large scale.
In the coming years, the market dynamic is likely to shift towards the Asian territory. This is in relation to the healthcare industry leader’s willingness to invest in developing countries. It is easy to develop research and innovation-based infrastructure in the territory with the presence of affordable raw materials and labour. With the government welcoming foreign investments, the Asian region can soon have the biggest venous stents market share.
Global Venous Stents Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Boston Scientific Corporation
- Becton, Dickinson and Company
- Gore Medical
- Cook Medical
- Optimed Medizinische Instrumente GmBH
- Medtronic
- Medica Germany GMBH & Co. KG
- Cordis Inc.
- MicroPort Scientific Corporation
- Koninklijke Phillips N.V.
- plus medica GmbH & Co. KG
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Technology |
|
| Breakup by Material |
|
| Breakup by Indication |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Venous Stents Market Overview
3.1 Global Venous Stents Market Historical Value (2017-2023)
3.2 Global Venous Stents Market Forecast Value (2024-2032)
4 Global Venous Stents Market Landscape
4.1 Global Venous Stents Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Venous Stents Product Landscape
4.2.1 Analysis by Technology
4.2.2 Analysis by Material
4.2.3 Analysis by Indication
4.2.4 Analysis by Application
5 Global Venous Stents Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Venous Stents Market Segmentation
6.1 Global Venous Stents Market by Technology
6.1.1 Market Overview
6.1.2 Iliac Vein Stent Technology
6.1.3 Wall Stent Technology
6.2 Global Venous Stents Market by Material
6.2.1 Market Overview
6.2.2 Nitinol
6.2.3 Elgiloy
6.3 Global Venous Stents Market by Indication
6.3.1 Market Overview
6.3.2 Chronic Deep Vein Thrombosis
6.3.3 Post-Thrombotic Syndrome (PTS)
6.3.4 May-Thurner’s Syndrome
6.3.5 Pelvic Congestion Syndrome (PCS)
6.3.6 Others
6.4 Global Venous Stents Market by Application
6.4.1 Market Overview
6.4.2 Leg
6.4.3 Chest
6.4.4 Abdomen
6.4.5 Others
6.5 Global Venous Stents Market by End User
6.5.1 Market Overview
6.5.2 Hospitals
6.5.3 Ambulatory Surgery Centers
6.5.4 Specialty Clinics
6.5.5 Cardiac Catheterization Labs
6.5.6 Others
6.6 Global Venous Stents Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Venous Stents Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Venous Stents Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Venous Stents Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Venous Stents Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Venous Stents Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Boston Scientific Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Becton, Dickinson and Company
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Gore Medical
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Cook Medical
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Optimed Medizinische Instrumente GmBH
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Medtronic
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Medica Germany GMBH & Co. KG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Cordis Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 MicroPort Scientific Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Koninklijke Phillips N.V.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 plus medica GmbH & Co. KG
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Global Venous Stents Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 1.03 billion in 2023, driven by the rising emphasis on reducing morbidity and mortality rates associated with venous diseases.
The market is anticipated to grow at a CAGR of 8.4% during the forecast period of 2024-2032, likely to reach a market value of USD 2.14 billion by 2032.
The prevalence of critical venous and cardiovascular diseases like deep vein thrombosis, post-thrombotic syndrome, May-Thurner’s syndrome are leading to high market demand. Moreover, there has been increased awareness among to masses regarding the usage to venous stents, hence the number of cases have increased.
Major merger acquisitions led by industry leaders like Olympus to bring in better quality and accurate solutions is a major market trend. With the increasing foreign investments and government aids, the market share is also shifting towards Asian area from North American region.
Iliac vein and wall stent technology are the most prevalent technologies used in the market.
Venous stents are used if a patient is suffering from chronic deep vein thrombosis, post-thrombotic syndrome (PTS), May-Thurner’s syndrome, and pelvic congestion syndrome (PCS), among others.
Venous stents find wide applications in legs, abdomen, chest, or other areas.
Nitinol and elgiloy are the most used materials to manufacture venous stents.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
The end users in the market include hospitals, ambulatory surgery centers, specialty clinics, and cardiac catheterization labs, among others.
Key players involved in the market are Boston Scientific Corporation, Becton, Dickinson and Company, Gore Medical, Cook Medical, optimed Medizinische Instrumente GmBH, Medtronic, Medica Germany GMBH & Co. KG, Cordis Inc., Koninklijke Phillips N.V., plus medica GmbH & Co. KG., and MicroPort Scientific Corporation.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER